EMVision Medical Devices (EMV) Stock Price, News & Analysis

Company Overview

EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 192,157 shs
• Average Volume: N/A
• Market Capitalization: A$165.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMV Stock Analysis - Frequently Asked Questions

How were EMVision Medical Devices' earnings last quarter?

EMVision Medical Devices Ltd (ASX:EMV) announced its quarterly earnings results on Tuesday, February, 26th. The company reported ($4.47) earnings per share (EPS) for the quarter. EMVision Medical Devices had a negative net margin of 24.33% and a negative trailing twelve-month return on equity of 22.53%.

Company Calendar

• Last Earnings: 2/26/2019
• Today: 7/13/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:EMV
• CIK: N/A
• Web: www.emvision.com.au
• Phone: 61 2 8667 5337
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$2.73 million
• Net Margins: -24.33%
• Pretax Margin: N/A
• Return on Equity: -22.53%
• Return on Assets: -7.95%

Debt

• Debt-to-Equity Ratio: 15.66
• Current Ratio: 6.40
• Quick Ratio: 8.04

Sales & Book Value

• Annual Sales: A$11.22 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 8.47
• Book Value: A$0.22 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 85,520,000
• Free Float: N/A
• Market Cap: A$165.05 million
• Optionable: Not Optionable
• Beta: 1.47